Baidu
map

2015临床试验论坛 MedSci专家发表主题演讲

2015-05-14 MedSci MedSci原创

2015临床试验论坛暨第四届中国临床研究沙龙即将于5月16日上海·国家会展中心 大会日程: B区B0-02会议室(通过1、2号馆间会展大道层/8米层到达) 9:00-9:30 来宾入场

2015临床试验论坛暨第四届中国临床研究沙龙即将于5月16日在上海·国家会展中心召开!

大会日程:

 

2015临床试验论坛

暨第四届中国临床研究沙龙

国家会展中心.5月16日

B区B0-02会议室(通过1、2号馆间会展大道层/8米层到达)

9:00-9:30

来宾入场

9:30-9:40

主办方致辞

9:40-10:10

临研立题与设计中的审评关切

国家卫计委卫生发展研究中心教授 程龙博士

10:15-10:45

上市后临床研究设计及统计分析

普瑞盛(北京)医药科技开发有限公司数据统计中心总监 朗素平

10:50-11:20

中国对于亚太研发策略的影响

武田制药医学总监 周伟博士

11:25-11:55

FSP本土化与临研质量

煌途医药质量保证总监 段忠成

12:00-13:00

午餐&午休

13:00-13:30

临床研究评价中的关注

信达生物制药(苏州)有限公司注册与临床研究副总裁 李娅杰

13:35-14:05

如何合理地设计临床研究?

梅斯医学Medsci 马志刚博士

14:10-15:40

概述医疗器械临床试验中三方职责与合作

奥咨达医疗器械服务集团董事副总经理 李强

15:45-16:15

一体化信息技术在临床研究中的应用

上海恒瑞医药数据管理高级总监 颜崇超博士

16:20-16:30

自由交流,活动结束

 

 

演讲嘉宾:

程龙 教授、医学博士,国家卫计委卫生发展研究中心

程龙,教授,医学博士,欧美同学会留美医学会副会长,中国中西医结合学会青年委员会委员,北京中医药学会心血管病专业委员会常务委员。国家卫生计生事业发展"十三五”规划前期研究重大课题之"卫生信息化对医疗卫生模式改变研究"课题负责人。曾就职于国家食品药品监督管理局药品审评中心,历任临床主审,项目负责人,主审报告人,高级审评员。2010年一2011年国家公派留学哈佛大学公共卫生学院,担任研究科学家,研究国家医药创新与风险管理体系,其间任哈佛医学院华裔专家学者联合会副主席。2001年获执业医师资格。程博士长年进行卫生政策研究与医药创新技术评价,其研究优势在于既能预见引领宏观政策导向,又能把握微观技术支持。发表学术论文30余篇,参编专业论著6部。

 

马志刚 博士,梅斯医学MedSci

复旦大学上海医学院临床医学本科毕业,复旦大学附属华山医院临床外科博士毕业。曾于上海复旦大学附属华山医院从事普外科、血管外科临床及科研教学工作,担任临床医师数年。擅长临床相关科研课题、论文的编辑、评审工作。马博士在MedSci医学部从事科研选题及论文评审的教育培训工作,曾先后受邀在上海中山医院、北京及多家三甲医院演讲,在指导医学课题设计与创新,以及论文发表方面积累了宝贵的经验。

段忠成 质量保证总监,煌途医药

执业医师,临床医学专业毕业,临床研究行业从业经验11年,曾就职于润东医药研发、Choicepharma、后加入煌途医药集团,历任临床研究总监、质量保证总监等职务,具有丰富的行业经验和医院资源,熟悉ICH-GCP及中国GCP,熟悉临床研究行业的各项药事法规,主持和参与临床研究项目超过80项,其中涉及多个1类新药和肿瘤药品及global研究,涉及研究中心超过500个,研究者超过3000个,与中国85%的基地合作过,目前专注于临床研究质量保证与行业模式创新方面的研究工作。

李娅杰 注册与临床研究副总裁,信达生物制药(苏州)有限公司

李娅杰,信达生物制药(苏州)有限公司临床研究负责人。2003年-2011年在中国食品药品监督管理局药品审评中心任临床专业审评员,负责呼吸、抗感染、五官领域化学药品和生物制品临床专业审评。2012年-2014年在MSD R&D (China)center任CRD及project team leader,负责糖尿病领域。

周伟 医学总监,武田制药

周伟博士,现任武田制药医学总监,负责亚太区域(日本除外)免疫学项目。周伟博士在制药研发领域拥有十多年经验,擅长亚太区研发策略的制定及执行。加入武田之前,周伟博士曾供职于诺华,施贵宝等多家世界500强公司。周伟博士拥有外科和制药科学双硕士和内科学博士学位。

颜崇超 数据管理高级总监,上海恒瑞医药

颜崇超,营养学博士。中国临床研究数据管理学组(CDMC)成员,美国数据管理学会(Society of Clinical Data Management)认证的临床数据管理经理 (CCDM)以及 SAS公司(SAS Institute)认证的高级程序员。现任上海恒瑞医药数据管理部高级总监。此前曾是辉瑞(中国)研发中心数据服务部的技术运营负责人,并在上海医药临床研究中心数据管理部任高级总监。 曾在美国勃林格殷格翰制药公司(BI)从事临床研究的生物统计与数据管理的技术应用和管理工作。先后在意大利高级卫生研究院、美国亚利桑那大学医学院和纽约大学医学院从事医学研究,并在国内外期刊上发表过40余篇学术论文。
主要成果:
《医药临床研究中的数据管理》书作者,2011年6月由科学出版社出版。 是我国第一本有关临床研究数据管理的专业著作,该书被国家药品食品监督管理局药品审评中心(CDE)的《临床试验数据管理工作技术指南》中的所引用;
作为专家组成员,参与CDE的《临床试验中的电子数据采集(EDC)技术指导原则》的制订,是 CDMC的《临床试验中的计算机系统验证的要求》的负责人;
精通临床研究的操作规范、法规要求,特别是临床研究领域信息化技术的应用;
在国内率先提出以系统控制流程并提高质量这一理念,并实现临床研究一体化、移动通讯化与国产化,极大地提高了临床研究管理的质量与效率,并节省了研发的时间与费用。

李强 董事副总经理, 奥咨达医疗器械服务集团

循证医学资深专家,中国科协资深讲习团成员;
中国科协青年讲学团青年骏马奖获得者;
国内第一部循证医学主编,广东省医学会循证医学专业委员会第一、二、三届副主委;
举办“临床科研方法学”继教项目近200场次,在全国巡回讲学500余场次;
从事临床医学科研课题、成果评价工作19年。

郎素平 数据统计中心总监,普瑞盛(北京)医药科技开发有限公司

在大学院校和CRO拥有12年数据管理和生物统计的经验;
专注于肿瘤,肝病,传染病,心血管,内分泌学,疫苗和医疗器械等领域;
成功的为40多个厂家在CFDA产品审评会上进行答辩;
现任普瑞盛数据统计中心总监;
曾在南京医科大学的流行病学与卫生统计学系任职;
山西医科大学流行病与卫生统计学专业,获硕士学位。

 

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2036887, encodeId=5c80203688e5d, content=<a href='/topic/show?id=bf8d2329e5a' target=_blank style='color:#2F92EE;'>#主题演讲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23297, encryptionId=bf8d2329e5a, topicName=主题演讲)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Fri Oct 09 12:56:00 CST 2015, time=2015-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26276, encodeId=7417262e65b, content=真想学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Mon Jun 08 12:11:00 CST 2015, time=2015-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24272, encodeId=bd67242e298, content=点赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b131625589, createdName=2015520llm, createdTime=Wed May 20 18:16:00 CST 2015, time=2015-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24104, encodeId=f4fb2410444, content=真想听听!, beContent=null, objectType=article, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Tue May 19 00:04:00 CST 2015, time=2015-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24105, encodeId=c0132410554, content=不错课程!, beContent=null, objectType=article, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Tue May 19 00:04:00 CST 2015, time=2015-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23901, encodeId=159e239013f, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 17 20:01:00 CST 2015, time=2015-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23646, encodeId=6c8323646a0, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUNfdk68bHutYruGyxbKDzPWH3agcmId19Yf94FiapyicN0LTg0jykhqIhjPQVdR08FGR399rBpZIg/132, createdBy=feae1624323, createdName=Dr.LV, createdTime=Sat May 16 12:04:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606504, encodeId=902216065048a, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat May 16 11:56:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23543, encodeId=349d2354396, content=真的想听听, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Thu May 14 22:59:00 CST 2015, time=2015-05-14, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2036887, encodeId=5c80203688e5d, content=<a href='/topic/show?id=bf8d2329e5a' target=_blank style='color:#2F92EE;'>#主题演讲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23297, encryptionId=bf8d2329e5a, topicName=主题演讲)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Fri Oct 09 12:56:00 CST 2015, time=2015-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26276, encodeId=7417262e65b, content=真想学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Mon Jun 08 12:11:00 CST 2015, time=2015-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24272, encodeId=bd67242e298, content=点赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b131625589, createdName=2015520llm, createdTime=Wed May 20 18:16:00 CST 2015, time=2015-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24104, encodeId=f4fb2410444, content=真想听听!, beContent=null, objectType=article, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Tue May 19 00:04:00 CST 2015, time=2015-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24105, encodeId=c0132410554, content=不错课程!, beContent=null, objectType=article, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Tue May 19 00:04:00 CST 2015, time=2015-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23901, encodeId=159e239013f, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 17 20:01:00 CST 2015, time=2015-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23646, encodeId=6c8323646a0, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUNfdk68bHutYruGyxbKDzPWH3agcmId19Yf94FiapyicN0LTg0jykhqIhjPQVdR08FGR399rBpZIg/132, createdBy=feae1624323, createdName=Dr.LV, createdTime=Sat May 16 12:04:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606504, encodeId=902216065048a, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat May 16 11:56:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23543, encodeId=349d2354396, content=真的想听听, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Thu May 14 22:59:00 CST 2015, time=2015-05-14, status=1, ipAttribution=)]
    2015-06-08 午夜星河

    真想学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2036887, encodeId=5c80203688e5d, content=<a href='/topic/show?id=bf8d2329e5a' target=_blank style='color:#2F92EE;'>#主题演讲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23297, encryptionId=bf8d2329e5a, topicName=主题演讲)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Fri Oct 09 12:56:00 CST 2015, time=2015-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26276, encodeId=7417262e65b, content=真想学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Mon Jun 08 12:11:00 CST 2015, time=2015-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24272, encodeId=bd67242e298, content=点赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b131625589, createdName=2015520llm, createdTime=Wed May 20 18:16:00 CST 2015, time=2015-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24104, encodeId=f4fb2410444, content=真想听听!, beContent=null, objectType=article, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Tue May 19 00:04:00 CST 2015, time=2015-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24105, encodeId=c0132410554, content=不错课程!, beContent=null, objectType=article, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Tue May 19 00:04:00 CST 2015, time=2015-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23901, encodeId=159e239013f, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 17 20:01:00 CST 2015, time=2015-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23646, encodeId=6c8323646a0, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUNfdk68bHutYruGyxbKDzPWH3agcmId19Yf94FiapyicN0LTg0jykhqIhjPQVdR08FGR399rBpZIg/132, createdBy=feae1624323, createdName=Dr.LV, createdTime=Sat May 16 12:04:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606504, encodeId=902216065048a, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat May 16 11:56:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23543, encodeId=349d2354396, content=真的想听听, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Thu May 14 22:59:00 CST 2015, time=2015-05-14, status=1, ipAttribution=)]
    2015-05-20 2015520llm

    点赞!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2036887, encodeId=5c80203688e5d, content=<a href='/topic/show?id=bf8d2329e5a' target=_blank style='color:#2F92EE;'>#主题演讲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23297, encryptionId=bf8d2329e5a, topicName=主题演讲)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Fri Oct 09 12:56:00 CST 2015, time=2015-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26276, encodeId=7417262e65b, content=真想学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Mon Jun 08 12:11:00 CST 2015, time=2015-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24272, encodeId=bd67242e298, content=点赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b131625589, createdName=2015520llm, createdTime=Wed May 20 18:16:00 CST 2015, time=2015-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24104, encodeId=f4fb2410444, content=真想听听!, beContent=null, objectType=article, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Tue May 19 00:04:00 CST 2015, time=2015-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24105, encodeId=c0132410554, content=不错课程!, beContent=null, objectType=article, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Tue May 19 00:04:00 CST 2015, time=2015-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23901, encodeId=159e239013f, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 17 20:01:00 CST 2015, time=2015-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23646, encodeId=6c8323646a0, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUNfdk68bHutYruGyxbKDzPWH3agcmId19Yf94FiapyicN0LTg0jykhqIhjPQVdR08FGR399rBpZIg/132, createdBy=feae1624323, createdName=Dr.LV, createdTime=Sat May 16 12:04:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606504, encodeId=902216065048a, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat May 16 11:56:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23543, encodeId=349d2354396, content=真的想听听, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Thu May 14 22:59:00 CST 2015, time=2015-05-14, status=1, ipAttribution=)]
    2015-05-19 yydlt

    真想听听!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2036887, encodeId=5c80203688e5d, content=<a href='/topic/show?id=bf8d2329e5a' target=_blank style='color:#2F92EE;'>#主题演讲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23297, encryptionId=bf8d2329e5a, topicName=主题演讲)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Fri Oct 09 12:56:00 CST 2015, time=2015-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26276, encodeId=7417262e65b, content=真想学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Mon Jun 08 12:11:00 CST 2015, time=2015-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24272, encodeId=bd67242e298, content=点赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b131625589, createdName=2015520llm, createdTime=Wed May 20 18:16:00 CST 2015, time=2015-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24104, encodeId=f4fb2410444, content=真想听听!, beContent=null, objectType=article, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Tue May 19 00:04:00 CST 2015, time=2015-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24105, encodeId=c0132410554, content=不错课程!, beContent=null, objectType=article, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Tue May 19 00:04:00 CST 2015, time=2015-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23901, encodeId=159e239013f, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 17 20:01:00 CST 2015, time=2015-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23646, encodeId=6c8323646a0, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUNfdk68bHutYruGyxbKDzPWH3agcmId19Yf94FiapyicN0LTg0jykhqIhjPQVdR08FGR399rBpZIg/132, createdBy=feae1624323, createdName=Dr.LV, createdTime=Sat May 16 12:04:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606504, encodeId=902216065048a, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat May 16 11:56:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23543, encodeId=349d2354396, content=真的想听听, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Thu May 14 22:59:00 CST 2015, time=2015-05-14, status=1, ipAttribution=)]
    2015-05-19 yydlt

    不错课程!

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2036887, encodeId=5c80203688e5d, content=<a href='/topic/show?id=bf8d2329e5a' target=_blank style='color:#2F92EE;'>#主题演讲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23297, encryptionId=bf8d2329e5a, topicName=主题演讲)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Fri Oct 09 12:56:00 CST 2015, time=2015-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26276, encodeId=7417262e65b, content=真想学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Mon Jun 08 12:11:00 CST 2015, time=2015-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24272, encodeId=bd67242e298, content=点赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b131625589, createdName=2015520llm, createdTime=Wed May 20 18:16:00 CST 2015, time=2015-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24104, encodeId=f4fb2410444, content=真想听听!, beContent=null, objectType=article, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Tue May 19 00:04:00 CST 2015, time=2015-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24105, encodeId=c0132410554, content=不错课程!, beContent=null, objectType=article, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Tue May 19 00:04:00 CST 2015, time=2015-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23901, encodeId=159e239013f, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 17 20:01:00 CST 2015, time=2015-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23646, encodeId=6c8323646a0, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUNfdk68bHutYruGyxbKDzPWH3agcmId19Yf94FiapyicN0LTg0jykhqIhjPQVdR08FGR399rBpZIg/132, createdBy=feae1624323, createdName=Dr.LV, createdTime=Sat May 16 12:04:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606504, encodeId=902216065048a, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat May 16 11:56:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23543, encodeId=349d2354396, content=真的想听听, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Thu May 14 22:59:00 CST 2015, time=2015-05-14, status=1, ipAttribution=)]
    2015-05-17 huaxipanxing

    看看

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2036887, encodeId=5c80203688e5d, content=<a href='/topic/show?id=bf8d2329e5a' target=_blank style='color:#2F92EE;'>#主题演讲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23297, encryptionId=bf8d2329e5a, topicName=主题演讲)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Fri Oct 09 12:56:00 CST 2015, time=2015-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26276, encodeId=7417262e65b, content=真想学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Mon Jun 08 12:11:00 CST 2015, time=2015-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24272, encodeId=bd67242e298, content=点赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b131625589, createdName=2015520llm, createdTime=Wed May 20 18:16:00 CST 2015, time=2015-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24104, encodeId=f4fb2410444, content=真想听听!, beContent=null, objectType=article, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Tue May 19 00:04:00 CST 2015, time=2015-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24105, encodeId=c0132410554, content=不错课程!, beContent=null, objectType=article, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Tue May 19 00:04:00 CST 2015, time=2015-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23901, encodeId=159e239013f, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 17 20:01:00 CST 2015, time=2015-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23646, encodeId=6c8323646a0, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUNfdk68bHutYruGyxbKDzPWH3agcmId19Yf94FiapyicN0LTg0jykhqIhjPQVdR08FGR399rBpZIg/132, createdBy=feae1624323, createdName=Dr.LV, createdTime=Sat May 16 12:04:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606504, encodeId=902216065048a, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat May 16 11:56:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23543, encodeId=349d2354396, content=真的想听听, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Thu May 14 22:59:00 CST 2015, time=2015-05-14, status=1, ipAttribution=)]
    2015-05-16 Dr.LV

    值得学习

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2036887, encodeId=5c80203688e5d, content=<a href='/topic/show?id=bf8d2329e5a' target=_blank style='color:#2F92EE;'>#主题演讲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23297, encryptionId=bf8d2329e5a, topicName=主题演讲)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Fri Oct 09 12:56:00 CST 2015, time=2015-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26276, encodeId=7417262e65b, content=真想学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Mon Jun 08 12:11:00 CST 2015, time=2015-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24272, encodeId=bd67242e298, content=点赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b131625589, createdName=2015520llm, createdTime=Wed May 20 18:16:00 CST 2015, time=2015-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24104, encodeId=f4fb2410444, content=真想听听!, beContent=null, objectType=article, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Tue May 19 00:04:00 CST 2015, time=2015-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24105, encodeId=c0132410554, content=不错课程!, beContent=null, objectType=article, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Tue May 19 00:04:00 CST 2015, time=2015-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23901, encodeId=159e239013f, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 17 20:01:00 CST 2015, time=2015-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23646, encodeId=6c8323646a0, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUNfdk68bHutYruGyxbKDzPWH3agcmId19Yf94FiapyicN0LTg0jykhqIhjPQVdR08FGR399rBpZIg/132, createdBy=feae1624323, createdName=Dr.LV, createdTime=Sat May 16 12:04:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606504, encodeId=902216065048a, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat May 16 11:56:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23543, encodeId=349d2354396, content=真的想听听, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Thu May 14 22:59:00 CST 2015, time=2015-05-14, status=1, ipAttribution=)]
  9. [GetPortalCommentsPageByObjectIdResponse(id=2036887, encodeId=5c80203688e5d, content=<a href='/topic/show?id=bf8d2329e5a' target=_blank style='color:#2F92EE;'>#主题演讲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23297, encryptionId=bf8d2329e5a, topicName=主题演讲)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Fri Oct 09 12:56:00 CST 2015, time=2015-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=26276, encodeId=7417262e65b, content=真想学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Mon Jun 08 12:11:00 CST 2015, time=2015-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24272, encodeId=bd67242e298, content=点赞!, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b131625589, createdName=2015520llm, createdTime=Wed May 20 18:16:00 CST 2015, time=2015-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24104, encodeId=f4fb2410444, content=真想听听!, beContent=null, objectType=article, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Tue May 19 00:04:00 CST 2015, time=2015-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24105, encodeId=c0132410554, content=不错课程!, beContent=null, objectType=article, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Tue May 19 00:04:00 CST 2015, time=2015-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23901, encodeId=159e239013f, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 17 20:01:00 CST 2015, time=2015-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23646, encodeId=6c8323646a0, content=值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUNfdk68bHutYruGyxbKDzPWH3agcmId19Yf94FiapyicN0LTg0jykhqIhjPQVdR08FGR399rBpZIg/132, createdBy=feae1624323, createdName=Dr.LV, createdTime=Sat May 16 12:04:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606504, encodeId=902216065048a, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat May 16 11:56:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23543, encodeId=349d2354396, content=真的想听听, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Thu May 14 22:59:00 CST 2015, time=2015-05-14, status=1, ipAttribution=)]
    2015-05-14 hbwang006

    真的想听听

    0

相关资讯

SCAI 2015:STEMI试验是否需要知情同意?

单中心HEAT-PPCI试验结果显示,与安慰剂相比,试验用干预药物可显著增加主要疗效终点的发生风险,鉴于研究在一开始时未获取受试者的知情同意,这一度引发了人们对ST段抬高型心肌梗死(STEMI)试验是否需要获取患者知情同意的争论。在SCAI 2015年会上,就“随机入选STEMI患者进行临床试验时是否需要获取患者的知情同意”,西奈山伊坎医学院的Roxana Mehran与圣路易斯大学的Michae

ACC 2015:将发布22项临床试验结果

全球心血管医生的学术盛会——美国心脏病学会年会(ACC 2015)将于3月14~16日在美国圣迭戈召开。本次大会共发布22项最新临床研究(Late-Breaking Clinical Trials)! PROMISE研究 稳定型冠心病患者的无创评估一直是心血管研究的热点,然而,目前并无相关大规模临床试验对这些评估策略进行比较. PROMISE研究是一项前瞻性的随机临床试验对两种冠心病

斯利康心血管药物Brilinta临床试验效果显著

近日一项临床试验表明,长期服用阿斯利康的Brilinta(替卡格雷)可以使具有心脏病或中风病史的患者的死亡率降低16%,这项研究可能会大幅增加这款药物的销量,对阿斯利康而言无疑是一利好消息,但对医生而言,开处方前要充分考虑该药物带来的风险和收益,尤其是该药物可能造成出血的风险。 波士顿布里翰妇女医院的研究人员Marc Sabatine表示,尽管Brilinta造成出血的风险增加,但是

JAMA:伐伦克林——戒烟者的福音

每年平均约有40%的吸烟人群尝试过2次戒烟,这个现象足以说明“吸烟有害身体健康”已经深入人心,并且一部分吸烟者试图摆脱香烟。虽然他们并没有做好马上戒掉烟的准备,但是却尝试减少吸烟量以达到戒烟的目标。但是效果通常不如人意,因为不加“外力”辅助的自我克制戒烟,很难熬过“烟瘾”这一关。因此JonO.Ebbert等人进行了一项随机、双盲、安慰剂对照的多国涉猎的临床试验以期探究在通过减少吸烟量逐步实现戒烟的

Neurology:年龄相关阿尔茨海默病临床试验结果的差别

我们的研究为了验证先前的假设,年龄较大受试者的认知结果下降率不同于相对年轻的的受试者,进而明确年龄分布对个人临床试验结果的潜在影响。研究方法:一个包含18项研究的meta数据库,来源于阿尔茨海默病合作研究和阿尔茨海默病神经影像组织,我们纳入了一个包含2793名参与者的队列作为人口基线数据,并且接受阿尔茨海默病认知分析量表(ADAS-cog)、临床痴呆分级(CDR-SB)或者细微精神状态检查(MMS

美临床试验专家或接手FDA

Robert Califf   图片来源:杜克大学 在过去的一周里,人们将注意力集中在了心脏病学家Robert Califf身上。2月5日,美国食品药品监督管理局(FDA)局长Margaret Hamburg宣布将于3月离开该机构。于是,有谣言称,刚被任命为FDA副局长的Califf,将接手Hamburg的职位。 Califf是一位说话温和的南方人,他对改善临床试验充满

Baidu
map
Baidu
map
Baidu
map